CSL
CSL Limited is a public company which is a parent company of the CSL Group. CSL business activities operate in the Human Health, JRH Biosciences, Animal Health and ZLB Plasma Services operations. CSL limited develops, manufactures and markets pharmaceutical products of biological origin. The company' s business is: - Health care; - Life-saving products derived from human plasma; - Pharmaceuticals and diagnostics essential to health; - Cell culture reagents for the pharmaceutical industry; - Veterinary vaccines and diagnostics to protect livestock and companion animals.
CSL
Industry:
Biotechnology Health Care Health Diagnostics Medical
Founded:
1916-01-01
Address:
Parkville, New South Wales, Australia
Country:
Australia
Website Url:
http://www.csl.com
Total Employee:
10001+
Status:
Active
Contact:
61393878454
Total Funding:
111 M USD
Technology used in webpage:
Apple Mobile Web Clips Icon Apache Mobile Non Scaleable Content Amazon JsDelivr Cloudflare JS CDN JS ASP.NET Apple Mobile Web App Capable JQuery CDN
Current Advisors List
Board_member
Board_member
Board_member
Board_member
Board_member
Board_member
Current Employees Featured
Ghazal Hariri Investigator @ CSL
Investigator
2019-01-01
John Shine Chairman @ CSL
Chairman
Sandro Krug Human Resources Director Intercontinental Commercial Operations @ CSL
Human Resources Director Intercontinental Commercial Operations
2022-01-01
Joy Linton Chief Financial Officer @ CSL
Chief Financial Officer
2021-03-01
Paul Perreault Chief Executive Office and Managing Director @ CSL
Chief Executive Office and Managing Director
Peter Turner President of CSL Behring @ CSL
President of CSL Behring
Brian A. McNamee CEO @ CSL
CEO
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-12-14 | Vifor Pharma | Vifor Pharma acquired by CSL | 11.7 B USD |
| 2017-08-28 | Calimmune | Calimmune acquired by CSL | 91 M USD |
| 2017-06-12 | Wuhan Zhong Yuan Rui De Biological Products | Wuhan Zhong Yuan Rui De Biological Products acquired by CSL | 352 M USD |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-09-28 | Ena Respiratory | CSL investment in Series A - Ena Respiratory | 11.7 M AUD |
| 2019-09-26 | Denteric | CSL investment in Series A - Denteric | 14 M AUD |
| 2000-05-30 | eBioinformatics | CSL investment in Venture Round - eBioinformatics | 10 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2020-02-24 | DMO appoints CSL as new stockbrokers to FGN |
Official Site Inspections
http://www.csl.com Semrush global rank: 318.65 K Semrush visits lastest month: 194.8 K
- Host name: csl.com
- IP address: 12.3.33.229
- Location: Atlanta United States
- Latitude: 33.9707
- Longitude: -84.3247
- Metro Code: 524
- Timezone: America/New_York
- Postal: 30338
More informations about "CSL"
Global Biotechnology Company | CSL
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Together they help ensure people everywhere get the treatments they need. ... The organization works to raise awareness about …See details»
Our Leadership - CSL
The Board is responsible for the oversight and strategic direction of CSL. It monitors operational and financial performance, human resources policies and practices, and approves the company's budgets and business plans. It is also …See details»
We Are CSL | CSL
CSL Vifor, a leader in iron deficiency and nephrology. Together, our combined and robust histories are delivering a healthier today and a better tomorrow for patients and people everywhere. Our unique combination of commercial …See details»
Our Corporate Profile | Global Biotechnology Company …
Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL -including our three businesses, CSL Behring, CSL Seqirus and CSL Vifor - provides lifesaving products to patients …See details»
Our Company - CSL Behring
It began with a promise. CSL Behring's parent company, CSL, was formed more than 100 years ago to save lives using the latest technologies. In the century since, CSL Behring has grown into a global biotechnology leader, driven by …See details»
Thought Leadership - CSL
Nov 14, 2023 CSL Chief Sustainability Officer Jeffrey Ball looks ahead to Earth Day on April 22 and shares highlights, including CSL’s renewable-linked power purchase agreement in …See details»
CSL Limited - Wikipedia
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma …See details»
CSL - Crunchbase Company Profile & Funding
CSL Limited is a public company which is a parent company of the CSL Group. CSL business activities operate in the Human Health, JRH Biosciences, Animal Health and ZLB Plasma …See details»
CSL Annual Report 2024
CSL Vifor views a solution to this in PBM: an evidence‑based approach to improve outcomes by preserving patient’s own blood. Due to the well-established benefits of PBM, there is positive …See details»
CSL - LinkedIn
CSL | 247,424 followers on LinkedIn. CSL is a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune …See details»
Our Businesses and Products - CSL
For over a century, we’ve been an unstoppable force, from developing medicines that save and improve lives to vaccines that protect them. Today, with the combined expertise of CSL …See details»
Sustainability at CSL - CSL Behring
CSL is committed to a healthier world. Our vision is a sustainable future for our employees, communities, patients and donors, inspired by innovative science and a values-driven culture. ... and ethical behaviors with integrity and further …See details»
CSL Company Profile - Office Locations, Competitors, Revenue
Oct 4, 2024 CSL has 5 employees across 2 locations and $14.69 b in annual revenue in FY 2024. See insights on CSL including office locations, competitors, revenue, financials, …See details»
Corporate Governance - CSL
The Board believes that CSL complies with the ASX Corporate Governance Council's Revised Corporate Governance Principles and Recommendations. Furthermore, the Board and …See details»
CSL - LinkedIn
CSL | 253,123 followers on LinkedIn. CSL is a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune …See details»
CSL Joins Blood & Beyond Initiative
Dec 10, 2024 Health authorities, including the World Health Organization, endorse an approach called patient blood management (PBM) to preserve and safeguard a patient’s own blood …See details»
Annual Reports | Global Biotechnology Company | CSL - CSL Limited
CSL's latest and archived Annual Reports. Set new initial goals in support of performance across CSL’s sustainability focus areas that seek to enable a healthier world, also embedding health …See details»
Major CSL master plan consult takes place Jan. 13
4 days ago An important step in Côte St. Luc’s master plan for the future of the city will take place at CSL city hall 7 p.m. Monday Jan. 13 when a legal public consultation takes place, part …See details»
Healthier Communities - CSL
CSL has evolved its sustainability strategy during FY2024, with the goal of deploying its resources to service stakeholders in the focus areas of Access and Affordability, Patient Experience and …See details»
Responsible & Resilient Supply Chain - CSL
CSL is a member of the Pharmaceutical Supply Chain Initiative (PSCI), an industry-based organisation committed to working collaboratively towards building responsible supply chains. …See details»